Click for best price
Chronic Obstructive Pulmonary Disease Therapeutics Market Size, Share 2023
This report contains market size and forecasts of Chronic Obstructive Pulmonary Disease Therapeutics in global, including the following market information:
The global Chronic Obstructive Pulmonary Disease Therapeutics market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Anti-inflammatory Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chronic Obstructive Pulmonary Disease Therapeutics include Abbott, Akorn, AbbVie, AstraZeneca, Boehringer Ingelheim, Cipla, GSK, Merck and Mylan, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Obstructive Pulmonary Disease Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Obstructive Pulmonary Disease Therapeutics Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Chronic Obstructive Pulmonary Disease Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Anti-inflammatory Drugs
- Bronchodilators
- Others
Global Chronic Obstructive Pulmonary Disease Therapeutics Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Chronic Obstructive Pulmonary Disease Therapeutics Market Segment Percentages, by Application, 2022 (%)
- General Hospitals
- Specialty Clinics
Global Chronic Obstructive Pulmonary Disease Therapeutics Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Chronic Obstructive Pulmonary Disease Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Chronic Obstructive Pulmonary Disease Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Chronic Obstructive Pulmonary Disease Therapeutics revenues share in global market, 2022 (%)
- Key companies Chronic Obstructive Pulmonary Disease Therapeutics sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Chronic Obstructive Pulmonary Disease Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Akorn
- AbbVie
- AstraZeneca
- Boehringer Ingelheim
- Cipla
- GSK
- Merck
- Mylan
- Novartis
- Pfizer
- Roche
- Teva
- Vectura
| Report Attributes |
Report Details |
| Report Title |
Chronic Obstructive Pulmonary Disease Therapeutics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
75 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Obstructive Pulmonary Disease Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Obstructive Pulmonary Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Obstructive Pulmonary Disease Therapeutics Overall Market Size
2.1 Global Chronic Obstructive Pulmonary Disease Therapeutics Market Size: 2022 VS 2030
2.2 Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Chronic Obstructive Pulmonary Disease Therapeutics Sales: 2018-2030
3 Company Landscape
3.1 Top Chronic Obstructive Pulmonary Disease Therapeutics Players in Global Market
3.2 Top Global Chronic Obstructive Pulmonary Disease Therapeutics Companies Ranked by Revenue
3.3 Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Companies
3.4 Global Chronic Obstructive Pulmonary Disease Therapeutics Sales by Companies
3.5 Global Chronic Obstructive Pulmonary Disease Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chronic Obstructive Pulmonary Disease Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chronic Obstructive Pulmonary Disease Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disease Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Chronic Obstructive Pulmonary Disease Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disease Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Anti-inflammatory Drugs
4.1.3 Bronchodilators
4.1.4 Others
4.2 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2023-2030
4.2.3 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
4.3 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales & Forecasts
4.3.1 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2023
4.3.2 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2023-2030
4.3.3 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
4.4 By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2022 & 2030
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2023-2030
5.2.3 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
5.3 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales & Forecasts
5.3.1 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2023
5.3.2 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2023-2030
5.3.3 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
5.4 By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2023-2030
6.2.3 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
6.3 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales & Forecasts
6.3.1 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2023
6.3.2 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2023-2030
6.3.3 By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2030
6.4.2 By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2030
6.4.3 US Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.4.4 Canada Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.4.5 Mexico Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2030
6.5.2 By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2030
6.5.3 Germany Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.5.4 France Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.5.5 U.K. Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.5.6 Italy Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.5.7 Russia Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.5.8 Nordic Countries Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.5.9 Benelux Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2030
6.6.2 By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2030
6.6.3 China Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.6.4 Japan Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.6.5 South Korea Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.6.6 Southeast Asia Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.6.7 India Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2030
6.7.2 By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2030
6.7.3 Brazil Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.7.4 Argentina Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Sales, 2018-2030
6.8.3 Turkey Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.8.4 Israel Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.8.5 Saudi Arabia Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
6.8.6 UAE Chronic Obstructive Pulmonary Disease Therapeutics Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.1.4 Abbott Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Key News
7.2 Akorn
7.2.1 Akorn Corporate Summary
7.2.2 Akorn Business Overview
7.2.3 Akorn Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.2.4 Akorn Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 Akorn Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.3.4 AbbVie Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.4.4 AstraZeneca Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 AstraZeneca Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.5.4 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Boehringer Ingelheim Key News
7.6 Cipla
7.6.1 Cipla Corporate Summary
7.6.2 Cipla Business Overview
7.6.3 Cipla Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.6.4 Cipla Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Cipla Key News
7.7 GSK
7.7.1 GSK Corporate Summary
7.7.2 GSK Business Overview
7.7.3 GSK Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.7.4 GSK Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 GSK Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.8.4 Merck Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.9.4 Mylan Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.10.4 Novartis Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News
7.11 Pfizer
7.11.1 Pfizer Corporate Summary
7.11.2 Pfizer Chronic Obstructive Pulmonary Disease Therapeutics Business Overview
7.11.3 Pfizer Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.11.4 Pfizer Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.11.5 Pfizer Key News
7.12 Roche
7.12.1 Roche Corporate Summary
7.12.2 Roche Chronic Obstructive Pulmonary Disease Therapeutics Business Overview
7.12.3 Roche Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.12.4 Roche Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.12.5 Roche Key News
7.13 Teva
7.13.1 Teva Corporate Summary
7.13.2 Teva Chronic Obstructive Pulmonary Disease Therapeutics Business Overview
7.13.3 Teva Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.13.4 Teva Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.13.5 Teva Key News
7.14 Vectura
7.14.1 Vectura Corporate Summary
7.14.2 Vectura Business Overview
7.14.3 Vectura Chronic Obstructive Pulmonary Disease Therapeutics Major Product Offerings
7.14.4 Vectura Chronic Obstructive Pulmonary Disease Therapeutics Sales and Revenue in Global (2018-2023)
7.14.5 Vectura Key News
8 Global Chronic Obstructive Pulmonary Disease Therapeutics Production Capacity, Analysis
8.1 Global Chronic Obstructive Pulmonary Disease Therapeutics Production Capacity, 2018-2030
8.2 Chronic Obstructive Pulmonary Disease Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Obstructive Pulmonary Disease Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Obstructive Pulmonary Disease Therapeutics Supply Chain Analysis
10.1 Chronic Obstructive Pulmonary Disease Therapeutics Industry Value Chain
10.2 Chronic Obstructive Pulmonary Disease Therapeutics Upstream Market
10.3 Chronic Obstructive Pulmonary Disease Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Obstructive Pulmonary Disease Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chronic Obstructive Pulmonary Disease Therapeutics in Global Market
Table 2. Top Chronic Obstructive Pulmonary Disease Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Share by Companies, 2018-2023
Table 5. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales by Companies, (K Units), 2018-2023
Table 6. Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chronic Obstructive Pulmonary Disease Therapeutics Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Chronic Obstructive Pulmonary Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Chronic Obstructive Pulmonary Disease Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disease Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), 2018-2023
Table 15. By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), 2023-2030
Table 16. By Application ? Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), 2018-2023
Table 20. By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), 2023-2030
Table 21. By Region ? Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), 2018-2023
Table 25. By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), 2023-2030
Table 26. By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2018-2023
Table 29. By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2023-2030
Table 30. By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2018-2023
Table 33. By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2023-2030
Table 34. By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2018-2023
Table 37. By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2023-2030
Table 38. By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2018-2023
Table 41. By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2023-2030
Table 42. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Sales, (K Units), 2023-2030
Table 46. Abbott Corporate Summary
Table 47. Abbott Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 48. Abbott Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Akorn Corporate Summary
Table 50. Akorn Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 51. Akorn Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. AbbVie Corporate Summary
Table 53. AbbVie Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 54. AbbVie Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. AstraZeneca Corporate Summary
Table 56. AstraZeneca Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 57. AstraZeneca Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 58. Boehringer Ingelheim Corporate Summary
Table 59. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 60. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Cipla Corporate Summary
Table 62. Cipla Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 63. Cipla Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 64. GSK Corporate Summary
Table 65. GSK Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 66. GSK Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 67. Merck Corporate Summary
Table 68. Merck Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 69. Merck Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 70. Mylan Corporate Summary
Table 71. Mylan Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 72. Mylan Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Novartis Corporate Summary
Table 74. Novartis Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 75. Novartis Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 76. Pfizer Corporate Summary
Table 77. Pfizer Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 78. Pfizer Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 79. Roche Corporate Summary
Table 80. Roche Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 81. Roche Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 82. Teva Corporate Summary
Table 83. Teva Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 84. Teva Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Vectura Corporate Summary
Table 86. Vectura Chronic Obstructive Pulmonary Disease Therapeutics Product Offerings
Table 87. Vectura Chronic Obstructive Pulmonary Disease Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 88. Chronic Obstructive Pulmonary Disease Therapeutics Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2023 (K Units)
Table 89. Global Chronic Obstructive Pulmonary Disease Therapeutics Capacity Market Share of Key Manufacturers, 2020-2023
Table 90. Global Chronic Obstructive Pulmonary Disease Therapeutics Production by Region, 2018-2023 (K Units)
Table 91. Global Chronic Obstructive Pulmonary Disease Therapeutics Production by Region, 2023-2030 (K Units)
Table 92. Chronic Obstructive Pulmonary Disease Therapeutics Market Opportunities & Trends in Global Market
Table 93. Chronic Obstructive Pulmonary Disease Therapeutics Market Drivers in Global Market
Table 94. Chronic Obstructive Pulmonary Disease Therapeutics Market Restraints in Global Market
Table 95. Chronic Obstructive Pulmonary Disease Therapeutics Raw Materials
Table 96. Chronic Obstructive Pulmonary Disease Therapeutics Raw Materials Suppliers in Global Market
Table 97. Typical Chronic Obstructive Pulmonary Disease Therapeutics Downstream
Table 98. Chronic Obstructive Pulmonary Disease Therapeutics Downstream Clients in Global Market
Table 99. Chronic Obstructive Pulmonary Disease Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Obstructive Pulmonary Disease Therapeutics Segment by Type
Figure 2. Chronic Obstructive Pulmonary Disease Therapeutics Segment by Application
Figure 3. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Obstructive Pulmonary Disease Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. Chronic Obstructive Pulmonary Disease Therapeutics Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Therapeutics Revenue in 2022
Figure 9. By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 10. By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 11. By Type - Global Chronic Obstructive Pulmonary Disease Therapeutics Price (US$/Unit), 2018-2030
Figure 12. By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 13. By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Application - Global Chronic Obstructive Pulmonary Disease Therapeutics Price (US$/Unit), 2018-2030
Figure 15. By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 16. By Region - Global Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 17. By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 18. By Country - North America Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 19. US Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 24. Germany Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. France Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 33. China Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 37. India Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 39. By Country - South America Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 40. Brazil Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disease Therapeutics Sales Market Share, 2018-2030
Figure 44. Turkey Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Chronic Obstructive Pulmonary Disease Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 48. Global Chronic Obstructive Pulmonary Disease Therapeutics Production Capacity (K Units), 2018-2030
Figure 49. The Percentage of Production Chronic Obstructive Pulmonary Disease Therapeutics by Region, 2022 VS 2030
Figure 50. Chronic Obstructive Pulmonary Disease Therapeutics Industry Value Chain
Figure 51. Marketing Channels
